FACIT (Fight Against Cancer Innovation Trust) — Full Portfolio

DNAstack builds Omics AI, a software suite that lets data custodians connect, protect, and share omics and health data across federated networks while enabling researchers to discover, access, and analyze it with AI tools.

AI & Machine LearningBiotechDigital HealthToronto, CA

MCMiro Cupak(Founder)in

Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.

BiotechDeep TechMedical DevicesToronto, CA

BLBrian Lichty(Founder, CEO)inCICarolina Ilkow(Founder, CSO)inJBJohn Bell(Founder, President)in

Co-investorsONOntario Centre of InnovationONOntario Centre of Innovation programs

Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.

BiotechHealthtech

JVJohn Valliant(Founder)in

Co-investorsHEHealthCapLULumira VenturesPIPivotal Life SciencesSESeroba Life SciencesVEVenture OntarioYSYsios Capital+6 more

Hyivy Health develops a holistic pelvic health device that treats, monitors, tracks, and helps prevent pelvic floor symptoms, along with connecting patients to clinicians and pelvic floor therapists.

Digital HealthFemTechHealthtechMedical Devices

RBRachel Bartholomew(CEO & Founder)inKamyar Rounidej(Former Co-founder & first Chief Technical Officer)

Co-investorsALAltitude AngelsBABacchus Venture CapitalBEBeresford VenturesSOSOSVTHThe 51 VenturesWOWomen's Equity Lab+3 more

KA Imaging develops X-ray imaging technologies and systems, including dual-energy radiography, phase contrast micro-CT, and amorphous selenium detectors.

HardwareHealthtechMedical DevicesWaterloo, CA

KSKarim S. Karim(Chief Technology Officer (CTO), Co-founder)inSGSina Ghanbarzadeh(Co-founder & Design Team Lead)inAKAmol Karnick(President & CEO)inPTPhilip Templeton(Chief Medical Officer (CMO))in

Co-investorsCRCreative Destruction Lab (CDL)INIn-Q-TelLALauder PartnersNONorthspring Capital Partners

NodeAI is a healthcare-focused company that builds algorithms and runs clinical trials with the aim of raising the standard of medical care.

AI & Machine LearningDigital HealthHealthtechMedical DevicesToronto, CA

WHWaël Hanna(Co-Founder / President & Chief Medical Officer)inAGAnthony Gatti(Co-Founder / Chief Technology Officer)inMBMackensey Bacon(Co-Founder / Chief Executive Officer)in

Co-investorsONOntario Centre of InnovationONOntario Centre of Innovation programs

Privacy Analytics provides data anonymization technology, advisory services, and tailored solutions to help organizations safely combine, share, and reuse sensitive personal data while managing privacy risk and meeting regulatory requirements.

CybersecurityData & InfrastructureHealthtech

Co-investorsVAVanedge CapitalVAVanedge Capital Limited Partnership

ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence.

BiotechHealthtechToronto

Juan Carlos Zuniga-Pflucker(Executive Officer, Director)

BoardFei Shen(Director)Ferdinand Massari(Director)

Co-investorsEIEisai Innovation, Inc.BOBoehringer Ingelheim Venture Fund

Qurcan develops veterinary pharmaceutical technology, with leadership holding advanced degrees in veterinary medicine, pharmaceutical sciences, and business development.

BiotechDeep TechHealthtechMedical DevicesCambridge, US

MAMohammad Ali Amini(Chief Executive Officer)inShirley Wu(Chief Scientific Officer)John Reid(Chief Business Officer)

Co-investorsTOToronto Innovation Acceleration Partners

Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.

Deep TechHealthtechMedical Devices

ARAlla ReznikADAndrew DeanCSCarmel Shields

BoardWayne Schnarr

Co-investorsTOToronto Innovation Acceleration Partners

Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.

BiotechMedical Devices

Arthur Fratamico(Executive Officer, Promoter)DGDeborah Geraghty, Ph.D.(President and Chief Executive Officer)

Co-investorsTOToronto Innovation Acceleration PartnersAMAmplitude Venture CapitalBIBill & Melinda Gates Foundation

Tenomix develops intelligent automation technology for cancer diagnostics and healthcare labs to improve diagnostic speed and accuracy while addressing staffing shortages and rising patient caseloads.

AI & Machine LearningHealthtechMedical DevicesRoboticsLondon, CA

Dr. (unnamed - identified as founder with Ph.D. in Pathology and Laboratory Medicine)(Founder & CEO)Dr. (unnamed - identified as physician-scientist with MD and PhD)(Co-founder)

Co-investorsONOntario Centre of Innovation

BiotechNew York, US

MBMichael Burgess(Executive Officer)Jose Manuel Otero(Executive Officer)Robert Gould(Director)inJHJane Henderson(Executive Officer)inStefan Larson(Director)Patrick Machado(Director)

Co-investorsBRBrace PharmaF-F-Prime CapitalFOFoothill VenturesVEVenture OntarioOROrbiMedPOPoint72+1 more

Xpan develops a single universal trocar for minimally invasive surgery (MIS) that accommodates all surgical instruments, aiming to replace traditional trocar access.

BiotechHardwareHealthtechMedical DevicesNobleton

SPSuresh Pai(Co-Founder & Board Director)inZAZaid Atto(Founder & CEO)in

Co-investorsUNUniversity of Toronto Entrepreneurship Hatchery

Yellowbird Diagnostics develops plug-and-play imaging dyes for common medical imaging procedures, designed to reveal disease markers for earlier diagnosis of conditions affecting the brain, heart, and kidneys.

BiotechHealthtechMedical Devices

Co-investorsFRFront Row Ventures